Dealroom.co – TechBio x AI Drug Discovery: Developing New Drugs Faster and Cheaper, Dec 2025

Summary

This report explores the intersection of Technology, Biology (TechBio), and Artificial Intelligence (AI) in accelerating drug discovery and development.

It highlights key trends such as the scaling of TechBio companies from theory to clinical execution, with 31 AI-discovered drug candidates in clinical phases in 2025. Over 30 pharmaceutical contracts were signed with TechBio companies, and more than 150 new TechBio companies were launched in 2025. AI accounts for approximately 30% of drugs discovered in R&D, positioning Europe as a leader in this transformational decade for health and bio sectors. Despite healthcare being one of the least digitized sectors, advances in computing, AI, and biology are driving a new wave of healthcare and life sciences innovation.

Region: European Union

Published: December 2025

Author(s): Dealroom.co

Language: English

Tech drivers: AI

Geopolitical drivers: Economic conditions Political instability and conflicts Regulatory changes Supply chains disruption

Found an inaccuracy in the description? Let us know 🙌

note

Save Clear

Latest Viewed Reports

WGS & Gallup – Global Leadership Report: What Followers Want, 2025

February 2025, WGS & Gallup

Leadership is fundamental to modern life, influencing everything from political power to family dynamics. Today's leaders face profound...